Incannex Healthcare (IXHL) Exchange Rate Effect (2023 - 2026)
Incannex Healthcare (IXHL) posted quarterly Exchange Rate Effect of $3.0 million for Q1 2026, up 10685.71% year-on-year from N/an in Q1 2025, and up 878.35% on a QoQ basis from -$388000.0 in Q4 2025.
Incannex Healthcare (IXHL) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Exchange Rate Effect for 4 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect rose 10685.71% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 950.34% YoY) and the FY2025 annual result came in at $306000.0, up 318.57% from the prior year.
- Exchange Rate Effect grew to $3.0 million in Q1 2026 per IXHL's latest filing, from -$388000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for IXHL reached as high as $3.0 million in Q1 2026 and fell as low as -$905000.0 in Q1 2024.
- A 4-year average of $197818.2 and a median of $28000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect slumped 792.86% — and 2026, when it jumped 10685.71%.
- Year by year, Exchange Rate Effect stood at $26000.0 in 2023, then soared by 115.38% to $56000.0 in 2024, then sank by 792.86% to -$388000.0 in 2025, then surged by 878.35% to $3.0 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $3.0 million, -$388000.0, and $269000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 3.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.02 Mn |
| Mar 31, 2026 | 3.02 Mn |
| Dec 31, 2025 | -388,000.00 |
| Dec 31, 2025 | -388,000.00 |
| Sep 30, 2025 | 269,000.00 |
| Sep 30, 2025 | 269,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 198,000.00 |
| Jun 30, 2024 | 198,000.00 |
| Mar 31, 2024 | -905,000.00 |
| Mar 31, 2024 | -905,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 26,000.00 |